價(jià)格 | ¥1670 | ¥9620 | ¥12500 |
包裝 | 2mg | 25mg | 50mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱:化合物 SIRT1-IN-2 | 英文名稱:SIRT1-IN-2 |
CAS:2470969-89-0 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號(hào): T60373 |
Name | SIRT1-IN-2 |
Description | SIRT1-IN-2 (compound 3h) is a potent and selective inhibitor of SIRT1 (silent information regulator 1) with an IC 50 of 1.6 μM [1]. |
In vitro | SIRT1-IN-2 (compound 3h) (0-100 μM, 48 h) inhibits the proliferation of Human cancer cell lines including K562, HCT-116, HepG2, A549, and MCF-7, and significantly reduces cytotoxicity on 293T cells and HUVEC [1]. Cell Cytotoxicity Assay Cell Line: Human cancer cell lines (K562, HCT-116, H460, HepG2, A549, HT-29, MCF-7) and normal cell lines (293T, HUVEC). [1] Concentration: 0, 0.01,0.1,1,10,100 μM Incubation Time: 48 h Result: Inhibited the proliferation of Human cancer cell lines including K562, HCT-116, HepG2, A549, and MCF-7, with IC 50 values of 51, 37, 40, 48, and 48 μM, respectively. And showed significantly less cytotoxic on 293T cells and HUVEC, with IC 50 values of > 100 and 45 μM, respectively. |
Storage | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥1000 |
VIP1年
|
康邁迪森(北京)醫(yī)藥科技有限公司
|
2024-12-12 | |
詢價(jià) |
VIP1年
|
陜西西化化學(xué)工業(yè)有限公司
|
2024-12-31 | |
詢價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2024-12-31 |